Table 1.
KM estimates of achieving a CD4 cell count >500/mm3 over time according to baseline CD4 cell count at cART initiation
| Baseline CD4+cell count, Median (IQR) | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | Year 6 | Year 7 |
|---|---|---|---|---|---|---|---|
| CD4<200 (n=5909), 100 [39–156] | 8% (7–9) | 21% (20–22) | 33% (31–34) | 43% (42–45) | 52% (50–54) | 60% (58–61) | 61% (59–62) |
| 200≤CD4<350 (n=5751), 269 [235–305] | 40% (39–42) | 61% (60–62) | 73% (72–74) | 81% (580–82) | 85% (84–86) | 88% (87–89) | 90% (89–91) |
| 350≤CD4<500 (n=2252), 404 [374–443] | 74% (72–76) | 87% (85–88) | 91% (90–92) | 94% (93–95) | 95% (93–96) | 96% (95–98) | 97% (95–98) |